On April 11 the company was upgraded to “Buy” from “Hold” in an announcement from Pivotal Research. On February 2 Nomura left the stock rating at “Buy” and moved up the price target from $900.00 to $925.00.
On February 2 investment analysts at KeyBanc held the company rating at “Overweight” but moved up the price target to $910.00 from $850.00. On February 2 investment analysts at Cantor Fitzgerald made no change to the company rating of “Buy” and raised the price target to $975.00 from $880.00.
Also read: Wanda’s Man in Hollywood Steps Down